Southern Acids (M) Bhd (XKLS:5134) Common Stock: RM171.3 Mil (As of Mar. 2026)


XKLS:5134 Southern Acids (M) Bhd XKLS:5134
69 GF Score
Price RM3.10
GF Value RM2.89
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Southern Acids (M) Bhd Common Stock?

Southern Acids (M) Bhd XKLS:5134 69 Common Stock is RM171.3 Mil as of Mar. 2026. GuruFocus rates XKLS:5134 with a GF Score™ of 69/100 and a GF Value™ of RM2.89 (Fairly Valued). The stock has 4 warning signs investors should review.

Southern Acids (M) Bhd's quarterly common stock stayed the same from Sep. 2025 (RM171.3 Mil) to Dec. 2025 (RM171.3 Mil) and stayed the same from Dec. 2025 (RM171.3 Mil) to Mar. 2026 (RM171.3 Mil).

Southern Acids (M) Bhd's annual common stock stayed the same from Mar. 2024 (RM171.3 Mil) to Mar. 2025 (RM171.3 Mil) and stayed the same from Mar. 2025 (RM171.3 Mil) to Mar. 2026 (RM171.3 Mil).

Southern Acids (M) Bhd Common Stock Historical Data

* Premium members only.

The historical data trend for Southern Acids (M) Bhd's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Southern Acids (M) Bhd Common Stock Chart

Southern Acids (M) Bhd Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 171.26 171.26 171.26 171.26 171.26

Southern Acids (M) Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.26 171.26 171.26 171.26 171.26
XKLS:5134
69GF Score
Southern Acids (M) Bhd XKLS:5134
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Southern Acids (M) Bhd Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of RM171.3 Mil mean?
Southern Acids (M) Bhd (XKLS:5134) has a Common Stock of RM171.3 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Southern Acids (M) Bhd and its competitors.
Is Southern Acids (M) Bhd's Common Stock too high?
Southern Acids (M) Bhd's current Common Stock is RM171.3 Mil. Overall, Southern Acids (M) Bhd has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Southern Acids (M) Bhd's Common Stock compare to HON and MMM?
Southern Acids (M) Bhd's Common Stock of RM171.3 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Conglomerates company?
A good Common Stock depends on the Conglomerates industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Southern Acids (M) Bhd and its competitors. Southern Acids (M) Bhd's current Common Stock is RM171.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Southern Acids (M) Bhd stock overvalued right now?
Based on GuruFocus' analysis, Southern Acids (M) Bhd (XKLS:5134) is currently considered Fairly Valued. The stock's GF Value™ is RM2.89, compared to a current price of RM3.10 — trading 7.3% above its estimated fair value. The current Common Stock is RM171.3 Mil. Southern Acids (M) Bhd's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Southern Acids (M) Bhd (XKLS:5134), the current Common Stock is RM171.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Southern Acids (M) Bhd (XKLS:5134) Overvalued in 2026?

Based on GuruFocus' analysis, Southern Acids (M) Bhd stock appears to be overvalued. The current stock price of RM3.10 is trading 7.3% above its estimated GF Value™ of RM2.89. GuruFocus considers Southern Acids (M) Bhd to be Fairly Valued.

Key valuation signals for XKLS:5134:

  • Common Stock: RM171.3 Mil
  • GF Value™: RM2.89 vs. price of RM3.10 (7.3% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the XKLS:5134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Southern Acids (M) Bhd Business Description

Address No. 8, Jalan Batu Tiga Lama, Level 29, Centro Tower, Klang, SGR, MYS, 41300
Southern Acids (M) Bhd is an investment holding and the provision of a management service company. The company's operating segment includes Oleochemical; Healthcare; Milling and Cultivation and Investments and services. It generates maximum revenue from the Milling and Cultivation segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Cultivation Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
69GF Score

Get the complete analysis for XKLS:5134

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.10
Price
RM2.89
GF Value